Rachel Hourigan has a BSc in Biochemistry from the University of Nottingham. Her studies provided her with a background of molecular biology as well as immunology and oncology and gained experience in both laboratory and literature research. She joined Beacon in January of 2023, and since has delivered insightful webinars, produced digests and conference presentations on the autoimmune drug development space.